Related articles
News Release
7.02.2022
Merz strengthens partnership with start-up Vensica and...
Merz Therapeutics, a company of the Merz Group and a leader in the field of neurotoxins, is expanding its strategic partnership with Vensica...
Read more
News Release
31.08.2021
XEOMIN® (incobotulinumtoxinA) receives european approval...
Today, Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins,...
Read more



